A new vaccine to prevent Lyme disease in humans may soon be available. Pfizer said it's planning to seek regulatory approval.

Michigan has seen cases skyrocket 168% in five years, but the new vaccine candidate offers hope with strong trial results and ...

Nearly half a million people are diagnosed and treated for Lyme disease in the U.S. every year, and Pennsylvania is a hot bed ...

The first human Lyme disease vaccine was 73% effective against the tick-borne illness, says Pfizer. They still plan to seek ...

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...

ROANOKE, Va. (WDBJ) - Pfizer said it plans to seek regulatory approval of a new vaccine for Lyme disease. Vaccines for Lyme ...

When the topic of Lyme disease comes up, Robert F. Kennedy Jr. often tells a story about standing in a bathtub in Westchester ...

Pfizer’s shot fell short of its initial trial goal, but with nearly half a million Americans infected each year, the company ...

TNX-4800 is a long-acting anti-Borrelia burgdorferi OspA human monoclonal antibody in development as a single-dose Lyme prophylactic Phase 1 ...

Biotech companies Valneva and Pfizer announced results from the Phase three trial of a Lyme disease vaccine candidate that ...

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease, but the company could see ...

A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed ...